Specific 14-3-3 isoforms could be targeted in biomedical treatments for many of the 14-3-3 related diseases that impact humanity world-wide, as many cancers and neurodevelopmental disorders [23]. The gene discussed is YWHAQ; the disease is neurodevelopmental disorder.